Population Attributable Fraction of Ischemic Heart Disease Associated to Hypertension in the Middle East and North Africa

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 248

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JCHR-4-1_005

تاریخ نمایه سازی: 11 مهر 1400

Abstract:

Background: Ischemic Heart Disease has been increasing in the Middle East and North Africa. Hypertension is an important modifiable risk factor of IHD and play an important role in the epidemic of IHD. Hypertension is responsible for about ۴۵% of IHD mortality and affects more than one billion people around the world. Objective: This study aims to quantify the population attributable fraction of IHD due to hypertension in the Middle East and North Africa. Methods: Sex-specific prevalence of hypertension was obtained from national and international studies. Moreover, age-adjusted hazard ratio (HR) of IHD and hypertension was extracted from the Tehran Lipid and Glucose Study (TLGS). HR and sex-specific prevalence of hypertension were used to calculate PAF of IHD due to hypertension in various countries of the region. Results: The sex-specific prevalence of hypertension was available for seventeen countries of the region. Hypertension ranged from ۴.۵% in Palestine to ۴۷% in Algeria in females and from ۲.۲%in Palestine to ۵۰.۷% in Oman in males. The fraction of IHD attributable to hypertension ranged from ۴.۳%in Palestine to ۳۲%in Algeria in females and from ۲.۲% in Palestine to ۳۳.۷%in Oman males. Conclusion: Up to ۳۳% IHD males mortality attributable to hypertension. It seems that hypertension is increasing in MENA and prevention programs is needed to control prevalence IHD.

Authors

مرضیه میرزاجانی

Zanjan University of Medical Sciences, Zanjan, Iran

مسعود میرزایی

Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd , Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Moran AE, Forouzanfar MH, Roth G, et al. Temporal Trends ...
  • Yusuf S, Reddy S, Ôunpuu S, et al. Global burden ...
  • Santulli G. Epidemiology of cardiovascular disease in the ۲۱st century: ...
  • Daugherty SL, Powers JD, Magid DJ, et al. Incidence and ...
  • Go AS, Bauman MA, King SMC, et al. An effective ...
  • Lim SS, Vos T, Flaxman AD, et al. A comparative ...
  • Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, ...
  • Guo F, He D, Zhang W, et al. Trends in ...
  • Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension ...
  • Basu S, Millett C. Social Epidemiology of Hypertension in Middle-Income ...
  • a global brief on hypertension [Internet]. ۲۰۱۳. Available from: http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/ ...
  • Mittal BV, Singh AK. Hypertension in the developing world: challenges ...
  • Antikainen R, Jousilahti P, Tuomilehto J. Systolic blood pressure, isolated ...
  • Wong ND, Thakral G, Franklin SS, et al. Prevention and ...
  • Metrics: Population Attributable Fraction (PAF) [Internet]. Available from: http://www.who.int/healthinfo/global_burden_disease/metrics_paf/en ...
  • Hadaegh F, Mohebi R, Cheraghi L, et al. Do Different ...
  • Azizi F, Rahmani M, Madjid M, et al. Target introduction ...
  • Khalili D, Sheikholeslami FH, Bakhtiyari M, et al. The Incidence ...
  • Woodward M. Epidemiology: study design and data analysis: CRC Press; ...
  • Abukhdeir H, Caplan L, Reese L, et al. Factors affecting ...
  • Temmar M, Labat C, Benkhedda S, et al. Prevalence and ...
  • Al Riyami A, Elaty MA, Morsi M, et al. Oman ...
  • AL-Nooh AA, Abdulabbas Abdulla Alajmi A, Wood D. The Prevalence ...
  • Esteghamati A, Meysamie A, Khalilzadeh O, et al. Third national ...
  • Abdella N, Al Arouj M, Al Nakhi A, et al. ...
  • Yamout R, Adib SM, Hamadeh R, et al. Peer Reviewed: ...
  • Bener A, Al-Suwaidi J, Al-Jaber K, et al. The prevalence ...
  • Al-Nozha MM, Abdullah M, Arafah MR, et al. Hypertension in ...
  • Al Ali R, Rastam S, Fouad FM, et al. Modifiable ...
  • Erem C, Hacihasanoglu A, Kocak M, et al. Prevalence of ...
  • Baynouna LM, Revel AD, Nagelkerke NJ, et al. High prevalence ...
  • Gunaid A, Assabri A. Prevalence of type ۲ diabetes and ...
  • Ibrahim MM. Epidemiology of hypertension in Egypt. Saudi Journal of ...
  • Beshyah SA. Non-communicable diseases and diabetes care guidelines: Epidemiology and ...
  • Tazi MA, Abir-Khalil S, Chaouki N, et al. Prevalence of ...
  • Ben RH, Skhiri H, Bougatef S, et al. [Hypertension prevalence, ...
  • Martiniuk AL, Lee CM, Lawes CM, et al. Hypertension: its ...
  • Gaziano TA, Bitton A, Anand S, al e. Growing epidemic ...
  • Danaei G, Ding EL, Mozaffarian D, et al. The preventable ...
  • Grau M, Subirana I, Elosua R, et al. Why should ...
  • Hozawa A. Attributable fractions of risk factors for cardiovascular diseases. ...
  • Abdulle AM, Nagelkerke NJ, Abouchacra S, et al. Under-treatment and ...
  • Whelton P, He J, Muntner P. Prevalence, awareness, treatment and ...
  • نمایش کامل مراجع